【2914】JT : Trametinib, the first MEK inhibitor, received U.S. regulatory approval,JT’s licence partner GlaxoSmithKline announced

Trametinib, the first MEK inhibitor, received U.S. regulatory approval,JT’s licence partner GlaxoSmithKline announced

出所:株経通信(株式会社みんかぶ)
PDFをダウンロード